Sculptra (Injectable Poly-L-Lactic Acid)
Authors:
- Douglas M. SidleDSDouglas M. Sidle
- 1 February 2007
- journal article
- review article
- Published by Elsevier in Facial Plastic Surgery Clinics of North America
- Vol. 15 (1) , 91-97
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Contemporary Surgical Management of HIV‐Associated Facial LipoatrophyOtolaryngology–Head and Neck Surgery, 2006
- Use of Polylactic Acid Implants to Correct Facial Lipoatrophy in Human Immunodeficiency Virus 1–Positive Individuals Receiving Combination Antiretroviral TherapyArchives of Dermatology, 2006
- NewFill for Skin AugmentationDermatologic Surgery, 2005
- Treatment of Facial Lipoatrophy With Intradermal Injections of Polylactic Acid in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophyJournal of the American Academy of Dermatology, 2005
- Safety of Sculptra®: a review of clinical trial dataJournal of Cosmetic and Laser Therapy, 2005
- Poly-L-Lactic AcidAmerican Journal of Clinical Dermatology, 2004
- Polylactic acid implants (New-Fill)® to correct facial lipoatrophy in HIV-infected patientsAIDS, 2003
- Tissue response and in vivo degradation of selected polyhydroxyacids: Polylactides (PLA), poly(3‐hydroxybutyrate) (PHB), and poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHB/VA)Journal of Biomedical Materials Research, 1993
- Resorption rate, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the ratJournal of Biomedical Materials Research, 1973